I still believe $NXEN has some potential right around the corner. They quietly hired a new IR / PR firm (announced in the last 10-Q), so I believe that’s a SIGN they have some things in the works. Why else would a company otherwise running low on funds hire an IR / PR firm?!
They have an Ivy League Medical School partner on the East Coast, but things were put on hold because of COVID.
Can’t wait for the updates. This stock has a LOW FLOAT of around 11.2 Million and it’s still a BARGAIN at the current share price, as it’s ran from $0.03 to $0.445 on the previous news.